Inactive Instrument

Highlights BioSig Technologies Inc Other OTC

Equities

US09073N1028

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Mayo Clinic-Phoenix Adopts Biosig Technologies, Inc.'s New Pure EP Subscription Model	Nov. 02	CI
Biosig Technologies, Inc. Enters into an Agreement with Sb Technology, Inc	23-09-05	CI
BioSig Technologies, Inc. Achieves Infrastructure and Technology Progress in Development of Generative AI Platform for Hospitals	23-08-24	CI
Biosig Technologies, Inc. Introduces New Subscription Model for Pure Ep? Platform, Offering Quicker Access to Latest Features, Customers	23-08-23	CI
Biosig Technologies, Inc.'s Pure Ep Platform Debuts New Automated Features in First Patient Cases	23-08-22	CI
BioSig Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
BioSig Technologies, Inc. Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare	23-06-27	CI
BioSig Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
BioSig Technologies Gets US Patent for Universal Notch Filter Technology	23-02-17	MT
BioSig's PURE EP(TM) System Demonstrates Potential Time and Cost Savings At the 15th APHRS Scientific Session in Singapore	22-12-14	CI
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for Its Digital Signal Processing Technology	22-10-24	CI
BioSig Technologies Signs Digital Signal Processing Research Deal With Cleveland Clinic; Shares Down Midday	22-10-24	MT
The Methodist Hospital acquired PURE EP(TM) System from BioSig Technologies, Inc..	22-10-06	CI
BioSig Technologies, Inc. Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module	22-09-22	CI
BioSig Technologies, Inc Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence	22-08-24	CI
BioSig Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioSig Technologies Inc Other OTC

Equities

US09073N1028

Highlights

Filters